Oncocytic intraductal carcinoma of parotid gland with a novel AGK::BRAF gene fusion.

Autor: Mauramo, M., Tarkkanen, J., Skalova, A., Leivo, I.

Publikováno v: Virchows Archiv: European Journal of Pathology; Nov2024, Vol. 485 Issue 5, p925-929, 5p

Oncocytic intraductal carcinoma of parotid gland with a novel AGK::BRAF gene fusion.

Autor: Mauramo M; Department of Pathology, University of Helsinki and Helsinki University Hospital, HUS Diagnostiikkakeskus, HUSLAB Patologia, PL 720, 00029 HUS Topeliuksenkatu 32, Helsinki, Finland. matti.mauramo@helsinki.fi., Tarkkanen J; Department of Pathology, University of Helsinki and Helsinki University Hospital, HUS Diagnostiikkakeskus, HUSLAB Patologia, PL 720, 00029 HUS Topeliuksenkatu 32, Helsinki, Finland., Skalova A; Department of Pathology, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic.; Bioptic Laboratory, Ltd., Pilsen, Czech Republic., Leivo I; Institute of Biomedicine, Pathology, University of Turku, and Turku University Hospital, Turku, Finland.

Publikováno v: Virchows Archiv : an international journal of pathology [Virchows Arch] 2024 Nov; Vol. 485 (5), pp. 925-929. Date of Electronic Publication: 2024 Sep 12.

Web-based prognostic tools for oral tongue cancer: An analysis of online predictors.

Autor: Wahab A; Department of Pathology, Faculty of Medicine, University of Helsinki, and Helsinki University Hospital (HUS), Helsinki, Finland.; Department of Oral and Maxillofacial Diseases, University of Helsinki, Helsinki, Finland., Bello IO; Department of Pathology, Faculty of Medicine, University of Helsinki, and Helsinki University Hospital (HUS), Helsinki, Finland.; Department of Oral Medicine and Diagnostic Sciences, King Saud University, Riyadh, Saudi Arabia., Alabi RO; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Department of Industrial Digitalization, School of Technology and Innovations, University of Vaasa, Vaasa, Finland., Mascitti M; Department of Clinical Specialistic and Dental Sciences, Marche Polytechnic University, Ancona, Italy., Troiano G; Department of Clinical and Experimental Medicine, Foggia University, Foggia, Italy., Mauramo M; Department of Pathology, Faculty of Medicine, University of Helsinki, and Helsinki University Hospital (HUS), Helsinki, Finland., Coletta RD; Department of Oral Diagnosis and Graduate Program in Oral Biology, School of Dentistry, University of Campinas, São Paulo, Brazil., Salo T; Department of Pathology, Faculty of Medicine, University of Helsinki, and Helsinki University Hospital (HUS), Helsinki, Finland.; Department of Oral and Maxillofacial Diseases, University of Helsinki, Helsinki, Finland.; Translational Immunology Research Program (TRIMM), Research Program Unit (RPU), University of Helsinki, Helsinki, Finland.; Department of Oncology, Comprehensive Cancer Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.; Research Unit of Population Health, and Medical Research Center Oulu, University of Oulu and Oulu University Central Hospital, Oulu, Finland.; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland., Almangush A; Department of Pathology, Faculty of Medicine, University of Helsinki, and Helsinki University Hospital (HUS), Helsinki, Finland.; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; University of Turku, Institute of Biomedicine, Pathology, Turku, Finland.; Faculty of Dentistry, Misurata University, Misurata, Libya.

Publikováno v: Oral diseases [Oral Dis] 2024 Jul 05. Date of Electronic Publication: 2024 Jul 05.

Oral Candida carriage and resistance against common antifungal agents in hematopoietic stem cell transplantation recipients.

Autor: Mauramo M; Department for Oral Health & Medicine, UZB University Centre for Dental Medicine Basel, University of Basel, Basel, Switzerland. matti.mauramo@helsinki.fi.; Department of Pathology, University of Helsinki and Helsinki University Hospital, HUS, Diagnostiikkakeskus, Patologia, PL 400, 00029 HUS, Helsinki, Finland. matti.mauramo@helsinki.fi., Tonoz N; Department for Oral Health & Medicine, UZB University Centre for Dental Medicine Basel, University of Basel, Basel, Switzerland., Halter J; Department of Hematology, University Hospital Basel, Basel, Switzerland., Joseph B; Saveetha Dental College and Hospitals, Saveetha Institute of Medical And Technical Sciences, Chennai, India., Waltimo T; Department for Oral Health & Medicine, UZB University Centre for Dental Medicine Basel, University of Basel, Basel, Switzerland.

Publikováno v: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2024 Feb 23; Vol. 32 (3), pp. 185. Date of Electronic Publication: 2024 Feb 23.

Bilberry (Vaccinium myrtillus L.) Powder Has Anticarcinogenic Effects on Oral Carcinoma In Vitro and In Vivo

Autor: Mauramo, M., Onali, T., Wahbi, W., Vasara, J., Lampinen, A., Mauramo, E., Kivimäki, A., Martens, S., Häggman, H., Sutinen, M., Salo, T.

Publikováno v: Antioxidants, Vol 10, Iss 1319, p 1319 (2021)
Antioxidants
Volume 10
Issue 8

Previous studies indicate that bilberry with high amounts of phenolic compounds can inhibit carcinogenic processes of colorectal cancer in vitro and in vivo. However, no studies have focused on the effects of bilberry on oral cancer. In this study, w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::104ebd9eea46ee7651234665f738da6b
https://www.mdpi.com/2076-3921/10/8/1319